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Abstract
Proinflammatory state of the brain increases the risk for seizure development. Neonatal Borna disease virus (BDV)-infection
of mice with neuronal overexpression of tumor necrosis factor-a (TNF) was used to investigate the complex relationship
between enhanced cytokine levels, neurotropic virus infection and reaction pattern of brain cells focusing on its role for
seizure induction. Viral antigen and glial markers were visualized by immunohistochemistry. Different levels of TNF in the
CNS were provided by the use of heterozygous and homozygous TNF overexpressing mice. Transgenic TNF, total TNF
(native and transgenic), TNF-receptor (TNFR1, TNFR2), IL-1 and N-methyl-D-aspartate (NMDA)-receptor subunit 2B (NR2B)
mRNA values were measured by real time RT-PCR. BDV-infection of TNF-transgenic mice resulted in non-purulent
meningoencephalitis accompanied by epileptic seizures with a higher frequency in homozygous animals. This correlated
with lower weight gain, stronger degree and progression of encephalitis and early, strong microglia activation in the TNF-
transgenic mice, most obviously in homozygous animals. Activation of astroglia could be more intense and associated with
an unusual hypertrophy in the transgenic mice. BDV-antigen distribution and infectivity in the CNS was comparable in TNF-
transgenic and wild-type animals. Transgenic TNF mRNA-expression was restricted to forebrain regions as the transgene
construct comprised the promoter of NMDA-receptor subunit2B and induced up-regulation of native TNF mRNA. Total TNF
mRNA levels did not increase significantly after BDV-infection in the brain of transgenic mice but TNFR1, TNFR2 and IL-1
mRNA values, mainly in the TNF overexpressing brain areas. NR2B mRNA levels were not influenced by transgene expression
or BDV-infection. Neuronal TNF-overexpression combined with BDV-infection leads to cytokine up-regulation, CNS
inflammation and glial cell activation and confirmed the presensitizing effect of elevated cytokine levels for the
development of spontaneous epileptic seizures when exposed to additional infectious noxi.
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Introduction
Epileptic seizures might arise after various brain insults either
already in infancy or later in life ranging from trauma, stroke,
brain tumors up to infections with or without febrile seizures
and status epilepticus. All of these events can trigger inflam-
matory processes in the brain and this proinflammatory state
represents a risk factor for seizure induction and maintenance
[1–6]. There is also increasing evidence that beside central
nervous system (CNS) inflammation with enhanced cytokine
levels, activation and dysfunction of microglia and astrocytes
cells with cytokine secretion play an important role for
occurrence of seizures in several different epilepsy forms [1–
10]. Most reports concentrate on the potential role of TNF, IL-
1 or Interleukin 6 (IL-6) .in the epileptogenic process [1–6,10].
Functional disturbances of the immune system such as
autoimmune CNS-diseases can also be associated with epileptic
seizures and seizures themselves are able to stimulate synthesis
of proinflammatory and proconvulsive cytokines [4,8,10–12].
Cytokines are also able to interfere with excitability of neurons
rapidly by interaction with glutamate and GABA receptors,
extracellular glutamate levels and blood brain barrier and on a
more prolonged base by effects on gene transcription [2,6,13].
However, despite substantial progress in epilepsy research, in
more than 66% of human epileptic patients the cause for
seizures remains unknown. Virus infections of the CNS, e.g.
herpesviruses, can serve as environmental trigger because about
50% of humans with encephalitis develop seizures and have a
higher risk to develop epilepsy later after recovery [14–19].
Recent experimental infections with picornavirus, herpes sim-
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plex virus, West Nile virus, measles virus or lymphocytic
choriomeningitis virus (LCMV) have substantiated this assump-
tion [14,15,20–23].
Natural and experimental infection with Borna disease virus
(BDV), a neurotropic, single stranded, negative sense RNA virus,
typically causes a severe neurological disorder (Borna disease, BD)
due to a progressive non-purulent meningoencephalitis accompa-
nied by virus persistence in the CNS [24–26]. Seizures might
occur in later stages of the natural disease. Main natural hosts are
horses and sheep, but in experimental settings, many warm-
blooded animal species can be easily infected. Recently, new avian
bornaviruses have been detected in psittacine birds suffering from
proventricular dilatation disease [27,28]. The association of BDV-
infection with human psychiatric diseases has been discussed
controversially; only the presence of BDV serum antibodies in
such patients is widely accepted to date [25,26,29,30].
Experimental BDV-infection of rodents is of great value to study
the virally induced immune-mediated neuropathologic processes
and the response of brain cells to inflammation and virus infection
[24–26,31]. Only neonatal mice develop clinical disease after
BDV-infection but clinical signs differ notably between various
mouse strains. Typical clinical signs in mice are hunched posture,
rough fur, weight loss and tilted head. Importantly, seizures have
yet not been noted in BDV-infected mice. In BDV-infection of
mice and rats, the invasion of immune cells into the CNS is
regularly accompanied by glial cell activation, up-regulation of
proinflammatory cytokines and CD4+ and CD8+ T-cells play a
crucial role in this process [25,31–34]. However, clearance of
BDV or cytolysis is generally not observed after experimental
infection of rodents and viral spread within the mouse brain is not
influenced by cytokines (e.g. interferon c [IFNc]) [25,34–36].
There is evidence that especially TNF represents a critical cytokine
for the antiviral immune response in various neurotropic virus
infections, e.g. rabies virus, West Nile virus and respiratory
syncytial virus [37–41]. Interestingly, TNF can also act as
proconvulsive or anticonvulsive factor depending on signalling
via TNF receptor 1 or 2 and contribute to a reduced seizure
threshold in models mimicking viral and bacterial infections in
children with respective long-term changes [2,4,6,10,13,20,42–
45]. TNF plays already a role in physiological brain homeostasis
since brains cells can secrete TNF and express TNF-receptors
[3,4,46–48].
Due to the versatile roles of TNF, several transgenic mice
expressing TNF under CNS-specific and non CNS-specific
promoters have been established so far [49–51]. The transgenic
mouse line used in the present study expressed the murine TNF
under the control of the promoter of the N-methyl-D-aspartate
(NMDA) receptor subunit NR2B/e2 and, therefore, demonstrated
a moderate TNF-overexpression restricted to forebrain regions of
the adult CNS [52]. These mice do not show clinical signs or brain
lesions despite a mild activation of microglia. Importantly, TNF-
overexpression is selectively active in defined brain regions where
BDV-replication takes place thereby affecting the BDV-induced
neuropathology. Homozygous and heterozygous transgenic mice
expressing different TNF-levels were infected with BDV and the
effects of TNF on clinical signs, inflammatory response, cytokine
induction, reaction pattern of brain cells and viral spread in the
CNS were analyzed. We describe a new model that allows
studying the complex interaction between a multifunctional
cytokine such as TNF, brain inflammation, reaction of brain cells
and neurotropic virus infection. This will improve our under-
standing of the presensitizing effects of elevated cytokine levels in
the CNS and the reciprocal neuroimmune interactions during
brain infections focusing on their impact for seizure induction.
Results
1. Clinical Examination
TNF-transgenic mice, especially homozygous mice, showed a
lower weight gain and developed spontaneous epileptic seizures.
All BDV- andmock-infected non-transgenic andTNF-transgenic
mice gainedweight between 21 to 42 dpi, but the amount of weight
gain differed significantly between the groups (Fig. 1). In general, a
lower weight gain was found in homozygous TNF-transgenic mice
compared to heterozygous and non-transgenic counterparts after
BDV-infection (p = 0.0128, p = 0.0450, respectively, table S1). In
addition, homozygous BDV-infected mice put on less weight than
respective mock-infected mice (p= 0.0275, table S1). Notably, a
significantly lower weight gain was also found in BDV-infected non-
transgenic mice compared to mock-infected animals (p = 0.0101,
table S1). Significant influence of the status of infection (p = 0.0091,
table S1) on the mean weight gain (p = 0.0217) were found in the
global statistical evaluation using the repeatedmeasurement analysis
of variances including the parameter transgenic status and status of
infection. In addition, the transgenic status showed only a mild
influence (p = 0.0814, table S1).
The clinical-neurological tests (activity, gait on the grid and on a
flat surface, ability to balance on a stick, motoric activity,
sensitivity, grasp and withdrawal reflex) revealed only mild
differences without statistical significance between homo- and
heterozygous TNF-transgenic and non-transgenic BDV-infected
mice and the respective mock-infected or non-infected cohort
(tables S2).
Interestingly, spontaneous epileptic seizures were exclu-
sively observed in BDV-infected transgenic animals during clinical
examinations. These seizures could be differentiated in complex
partial and generalized seizures. The complex partial and
generalized seizure lasted up to 30 and 50 sec, respectively. The
complex partial seizures started with a tonic phase, in which the
animals head turned rigidly upwards and back simultaneously with
bilateral forelimb extension. The longer lasting generalized
seizures began similarly, but the 10–20 sec lasting tonic phase
was followed by a tonic-clonic phase. This phase was characterized
by a rapid bilateral hind limb thrusting leading to vigorous
bouncing. 100% of the mice suffering from generalized seizures
died during the tonic-clonic seizures. Seizures appeared more
frequently in homozygous transgenic BDV-infected mice starting
at 21 dpi. In contrast, seizures were first seen at 42 dpi in
heterozygous transgenic animals (Fig. 2). No form of seizures was
observed in non-transgenic BDV-infected mice or any non-
infected TNF transgenic or mock-infected TNF transgenic animal.
All three BDV-infected mouse groups showed mild gait
abnormalities and problems balancing on a stick at 35 dpi. All
mock-infected mice, independent of their transgenic status,
displayed no clinical signs and were ranged into normal scores
of the clinical-neurological tests.
2. Expression of Transgenic TNF (TNFtg) mRNA, Total TNF
(TNFto) mRNA, IL-1 mRNA, TNFR1 mRNA, TNFR2 mRNA
and NR2B mRNA
TNFtg mRNA was present only in the transgenic animals. Total
TNF (TNFto) mRNA values were significantly higher in
transgenic mice with highest copy numbers in homozygous mice
indicating that TNFtg induced additional native TNF mRNA
expression. No significant increase of any TNF mRNA was
detected in transgenic animals after BDV-infection. IL-1 mRNA
levels increased significantly in all animal cohorts after BDV-
infection. After BDV-infection IL-1, TNFR1 and TNFR2 mRNA
levels increased significantly predominantly in brain areas with
TNF-Overexpression in BDV-Infected Mouse Brains
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TNF-overexpression. Neither transgene expression nor BDV-
infection caused significant changes in NR2B mRNA expression.
All mRNA values were analyzed 42 dpi in highly TNF-
overexpressing areas (cortex cerebri, striatum, hippocampus),
compared to a non-expressing area (cerebellum) and subjected
to further statistical analysis (tables S3, S4).
TNFtg mRNA levels yielded in average between 5.776102 and
6.826102 normalized copies in the non-infected heterozygous
mice and between 5.856102 and 6.616102 normalized copies in
the non-infected homozygous animals. After BDV-infection,
TNFtg mRNA copy numbers between 4.226102 and 8.276102
in the heterozygous mice and between 5.876102 and 8.96102 in
the homozygous mice in the cerebral cortex, hippocampus and
striatum were measured (Fig. 3). Normalized copy numbers in the
cerebellum ranged from 2 to 42 in the transgenic mouse groups
regardless of BDV-infection. Therefore, TNFtg mRNA copy
numbers were significantly higher in the cerebral cortex,
hippocampus and striatum when compared to the cerebellum in
Tg/– non-infected and infected mice (p,0.01) and in Tg/Tg non-
infected mice (p,0.01) and infected animals (p,0.05). No TNFtg
mRNA was detected in the wild-type mice in any brain area.
TNFto mRNA copy numbers consisted of transgenic and
native TNF mRNA. At day 42 p.i., non-infected wild-type mice
did not express hardly any TNFto mRNA but values increased up
to 49 copies after BDV-infection only in the cerebellum. In the
heterozygous non-infected mice TNFto mRNA values ranged
between 1.046103 and 1.376103 and between 1.196103 and
1.796103 copies in the homozygous non-infected mice in the TNF
overexpressing areas (Fig. 4). Interestingly, after BDV-infection,
TNFto mRNA levels reached at maximum 2.316103 copies in the
Tg/– animals and 3.096103 in the Tg/Tg mice in the
hippocampus with lower levels in the other transgene expressing
areas (Tg/–: 9.4610221.416103 copy numbers, Tg/Tg:
1.46610321.776103 copy numbers; Fig. 4). Normalized copy
numbers in the cerebellum ranged from 53 to 99 in the transgenic
mouse groups regardless of BDV-infection. Similar as TNFtg
mRNA expression, total TNF mRNA copy numbers were
significantly higher in the cerebral cortex, hippocampus and
striatum when compared to the cerebellum in Tg/– and Tg/Tg
non-infected and infected mice (p,0.0001). By statistical analysis a
significant increase of TNFto mRNA could not be documented in
any brain area in both transgenic cohorts after BDV-infection
when compared to the respective non-infected cohort. This was
only found in the wild-type mice (p,0.0001). However, TNFto
mRNA levels were significantly higher in transgenic mice than in
the wild-type animals and even significantly higher in the
homozygous mice compared to the heterozygous cohort in a
global comparison. Moreover, transgenic TNF was able to induce
native TNF mRNA.
In all mouse groups, a low constitutive IL-1 mRNA expression
was detected with values between 5 and 50 copy numbers. After
BDV-infection, IL-1 mRNA levels increased significantly in all
animal cohorts when compared to the respective non-infected
mouse group (copy numbers in the different brain areas:–/–: 38 –
57, p,0.005; Tg/–: 1.33610221.86102, p,0.001; Tg/Tg:
1.07610221.376102; p,0.05; Fig. 5). Copy numbers were
significantly higher in the Tg/– and Tg/Tg mice when compared
to wild-type mice regardless of infection status in the cerebral
cortex, hippocampus and striatum (p,0.052p,0.001). In the
transgenic non-infected and infected mice significantly lowest copy
numbers of IL-1 mRNA were measured in the cerebellum
(p,0.052p,0.001).
Constitutive TNFR1 mRNA expression was found in all non-
infected mouse groups with values ranging between 79 and
2.226102 copies. After BDV-infection, TNFR1 mRNA levels
increased significantly in the hippocampus (p = 0.0391) and in the
cerebellum (p= 0.0009) in the wild-type mice and in the transgenic
areas cerebral cortex, hippocampus and striatum in the Tg/– and
Figure 1. Development of weight gain in mock-infected and BDV-infected mice. TNF-transgenic animals gained less weight than the wild-
type mice after BDV-infection. In general, all BDV-infected mice groups exhibited al lower weight gain when compared to mock-infected animals. dpi:
days post infection, –/–: non-transgenic mice, Tg/–: heterozygous transgenic mice, Tg/Tg: homozygous transgenic mice, BDV: BDV-infected, mock:
mock-infected, arithmetic mean.
doi:10.1371/journal.pone.0041476.g001
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Tg/Tg mice (p = 0.0431–p,0.0001, Fig. 6). This indicated that
TNFR1 mRNA copies were highest in areas with high amounts of
TNFtg and TNFto mRNA.
Constitutive TNFR2 mRNA values ranged between 44 and
2.476102 copies in the non-infected cohorts. After BDV-infection,
a significant increase of TNFR2 mRNA levels was measured in all
animal cohorts except for the hippocampus in the wild-type mice
(copy numbers for the different brain areas: –/–:
1.44610223.246102, Tg/–: 1.83610221.816103, Tg/Tg:
1.26610221.196103 copy numbers; p,0.052p,0.001, Fig. 7).
Non-infected and infected transgenic animals depicted significant-
ly higher TNFR2 mRNA values in the TNF-overexpressing areas
when compared to the cerebellum (p,0.012p,0.0001).
Copy numbers of NR2B mRNA yielded between 3.96102 and
7.136103 in the non-infected cohorts and between 3.186102 and
6.816103 in the BDV-infected mouse groups. Significantly lowest
copy numbers were found in the cerebellum regardless of
transgene or infection status (p,0.0001, Fig. 8). Neither transgene
expression nor BDV-infection caused significant changes in NR2B
mRNA expression.
3. Inflammatory Reaction and Viral Infection of the Brain
The inflammatory reaction, microglia activation and type of
astroglial reaction correlated strongly with the transgene status of
the animals despite comparable viral spread and infectivity in
transgenic and non-transgenic mice. Highest inflammatory scores
and earliest, strongest microglia activation were found in the
homozygous mice.
Non-transgenic mice showed a mild immune cell infiltra-
tion without progression during the investigation period (Figs. 9A,
10). In contrast, in both TNF-overexpressing transgenic mice
groups a progressive severe non-purulent meningoencephalitis
with astrogliosis and activation of microglia was noted; only
astrocytes were activated in the wild-type mice (Figs. 9B–I, 10, 11).
Interestingly, homozygous TNF-transgenic animals showed higher
inflammatory scores than heterozygous BDV-infected mice at all
time points investigated. Heterozygous and homozygous TNF-
transgenic BDV-infected mice showed a significant increase of
invading immune cells consisting of macrophages, T-cells and B-
cells (data not shown) until 49 dpi (Tg/– p= 0.004; Tg/Tg
p= 0.0024). Statistically significant differences in the inflammatory
reaction between BDV-infected transgenic animals and BDV-
infected non-transgenic mice were detected from day 35 p.i. on
(35 dpi, –/– vs. Tg/Tg: p = 0.0357; 42 dpi –/– vs. Tg/–:
p = 0.0256, –/– vs. Tg/Tg: p = 0.0416; 49 dpi –/– vs. Tg/–:
p = 0.0281, –/– vs. Tg/Tg: p = 0.0416, table S2). Infiltration with
mononuclear cells was present in all groups from 21 dpi on and
was mainly found perivascularly in all three BDV-infected animal
groups with some additional parenchymal invasion only in the
transgenic animals starting 28 dpi. Immune cell infiltrates were
predominantly located in all cortical regions investigated, striatum
and thalamus. Both TNF-transgenic mice groups showed surpris-
Figure 2. Frequency of seizures in BDV-infected mice. Spontaneous epileptic seizures were exclusively observed in BDV-infected transgenic
animals and appeared more frequently in homozygous transgenic BDV-infected mice starting 21 dpi. Seizures were first noted 42 dpi in
heterozygous transgenic animals. dpi: days post infection, –/–: non-transgenic mice, Tg/–: heterozygous transgenic mice, Tg/Tg: homozygous
transgenic mice
doi:10.1371/journal.pone.0041476.g002
TNF-Overexpression in BDV-Infected Mouse Brains
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Figure 3. Transgenic TNF (TNFtg) mRNA values in different brain areas in TNF-transgenic and wild-type mice. TNFtg mRNA was
present only in the transgenic animals. TNFtg mRNA copy numbers were significantly higher in the cerebral cortex, hippocampus and striatum when
compared to the cerebellum in Tg/– and Tg/Tg animals regardless of BDV-infection. No TNFtg mRNA was detected in the wild-type mice in any brain
area. dpi: days post infection, –/–: non-transgenic mice, Tg/–: heterozygous transgenic mice, Tg/Tg: homozygous transgenic mice, geometric mean,
bar: distribution factor
doi:10.1371/journal.pone.0041476.g003
Figure 4. Total TNF (TNFto) mRNA values in different brain areas in TNF-transgenic and wild-type mice. TNFto mRNA values were
significantly higher in transgenic mice and consisted of approximately 50% native TNF mRNA indicating that TNFtg induced native TNF mRNA
expression. Highest copy numbers were found in homozygous mice. No significant increase of any TNF mRNA was detected in transgenic animals
after BDV-infection but values were highest in the hippocampus. dpi: days post infection, –/–: non-transgenic mice, Tg/–: heterozygous transgenic
mice, Tg/Tg: homozygous transgenic mice, geometric mean, bar: distribution factor.
doi:10.1371/journal.pone.0041476.g004
TNF-Overexpression in BDV-Infected Mouse Brains
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Figure 5. IL-1 mRNA values in different brain areas in TNF-transgenic and wild-type mice. IL-1 mRNA levels increased significantly in all
animal cohorts after BDV-infection but copy numbers were significantly higher in the transgenic mice when compared to wild-type mice regardless
of infection status. Highest values were detected TNF overexpressing areas. dpi: days post infection, –/–: non-transgenic mice, Tg/–: heterozygous
transgenic mice, Tg/Tg: homozygous transgenic mice, geometric mean, bar: distribution factor.
doi:10.1371/journal.pone.0041476.g005
Figure 6. TNFR1 mRNA values in different brain areas in TNF-transgenic and wild-type mice. After BDV-infection TNFR1 mRNA levels
increased significantly in transgenic mice, mainly in the brain areas with TNF-overexpression. dpi: days post infection, –/–: non-transgenic mice, Tg/–:
heterozygous transgenic mice, Tg/Tg: homozygous transgenic mice, geometric mean, bar: distribution factor.
doi:10.1371/journal.pone.0041476.g006
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ingly little inflammatory reaction in the hippocampus. Even at the
peak of the inflammatory response, the hippocampus displayed no
or only mild immune cell infiltration in both TNF-transgenic
groups despite high TNFtg and TNFto mRNA values (see above).
Despite the remarkable inflammatory lesions in transgenic BDV-
infected mice, neither in TNF-transgenic nor in non-transgenic
Figure 7. TNFR2 mRNA values in different brain areas in TNF-transgenic and wild-type mice. After BDV-infection TNFR2 mRNA levels
increased significantly in the transgenic mice, mainly in the brain areas with TNF-overexpression. dpi: days post infection, –/–: non-transgenic mice,
Tg/–: heterozygous transgenic mice, Tg/Tg: homozygous transgenic mice, geometric mean, bar: distribution factor.
doi:10.1371/journal.pone.0041476.g007
Figure 8. NR2B mRNA values in different brain areas in TNF-transgenic and wild-type mice. Neither transgene expression nor BDV-
infection caused significant changes in NR2B mRNA expression. dpi: days post infection, –/–: non-transgenic mice, Tg/–: heterozygous transgenic
mice, Tg/Tg: homozygous transgenic mice, geometric mean, bar: distribution factor.
doi:10.1371/journal.pone.0041476.g008
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animals, obvious neuronal necrosis was present in any brain region
investigated, even not in the hippocampus. This was furthermore
confirmed by Kresyl-violet staining (data not shown).
In the HE-stained sections, a significant increase of microglia
occurred only in homozygous (p = 0.0105) and heterozygous
(p = 0.0007) BDV-infected TNF-transgenic mice starting 21 dpi.
(Figs. 9D–F, 11, table S2) which was strongest in the homozygous
mice. At 42 and 49 dpi, in both transgenic BDV-infected mice
groups and additionally at 28 dpi in Tg/Tg animals, the numbers
of activated microglia were significantly higher than in wild-type
Figure 9. Inflammation, glial activation and viral distribution in the brain of BDV-infected TNF-transgenic and wild-type mice. A–F
Hematoxylin and eosin staining: Mild inflammatory reaction and no microglia activation in non-transgenic BDV-infected mice (A, higher magnification
in D). In contrast, moderate to severe inflammatory reaction and microglia activation in heterozygous (B, higher magnification in E) and homozygous
(C, higher magnification in F) TNF-transgenic mice. TNF-overexpressing striatum, 42 dpi Hematoxylin and eosin staining was used to assess the
degree of encephalitis and number of reactive microglia cells. G–I GFAP-immunostaining: Astrogliosis in all BDV-infected mice groups with more
GFAP-positive astrocytes in the transgenic animals. GFAP-immunostaining was carried out to assess the number and morphology of activated
astrocytes as GFAP expressing cells. TNF-overexpressing striatum, 42 dpi –/– J–L Immunostaining for the viral nucleoprotein: Comparable viral
distribution within the brain in all BDV-infected mice groups. Immunostaining for the viral nucleoprotein was used to assess the number of BDV-
infected cells. TNF-overexpressing striatum, 42 dpi –/–: non-transgenic mice, Tg/–: heterozygous transgenic mice, Tg/Tg: homozygous transgenic
mice,scale bars: 100 mm (A–C; G–L); 50 mm (D–F).
doi:10.1371/journal.pone.0041476.g009
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BDV-infected animals (28 dpi Tg/Tg: p= 0.0210; 42 dpi Tg/–:
p = 0.0265, Tg/Tg: p = 0.0436; 49 dpi Tg/–: p= 0.0179, Tg/Tg:
p = 0.0436, table S2). Non-transgenic BDV-infected animals
showed only occasionally rod shaped activated microglia up to
49 dpi. Rod shaped cells regularly expressed mac-1a. At day 42
p.i., the immunostained perivascular microglia/macrophages
represent 37.6% in the –/–, 34.7% in the Tg/– and 37.8% in
the Tg/Tg mice of the total perivascular cell count.
From 14 days p.i. on, an astrogliosis was observed in both
BDV-infected transgenic mice groups, but also in BDV-infected
non-transgenic mice despite only mild inflammatory lesions
(Figs. 9G–I, Fig. S1). However, between 21 and 42 dpi, the score
Figure 10. Degree of inflammatory reaction in the brain of BDV-infected animals. Wild-type mice showed a mild immune cell infiltration
without progression during the investigation period whereas in both TNF-overexpressing transgenic mice groups a progressive severe non-purulent
meningoencephalitis was noted. Highest inflammatory scores were found in the homozygous mice. Score for the inflammatory reaction: 0: no, 1:
mild, 2: moderate, 3: severe inflammatory reaction; score for the astrogliosis: 0: no, 1: mild, 2: moderate, 3: severe astrogliosis, p.i.: post infection, –/–:
non-transgenic mice, Tg/–: heterozygous transgenic mice, Tg/Tg: homozygous transgenic mice, median, bar: minimal/maximal value.
doi:10.1371/journal.pone.0041476.g010
Figure 11. Average number of activated microglia in BDV-infected mice. Microglia increased significantly only in the TNF-transgenic BDV-
infected mice starting 21 dpi. Earliest strongest microglia was found in the homozygous mice. dpi: days post infection, –/–: non-transgenic mice,
Tg/–: heterozygous transgenic mice, Tg/Tg: homozygous transgenic mice, arithmetic mean, bar: minimal/maximal value.
doi:10.1371/journal.pone.0041476.g011
TNF-Overexpression in BDV-Infected Mouse Brains
PLoS ONE | www.plosone.org 9 July 2012 | Volume 7 | Issue 7 | e41476
for GFAP-expressing astrocytes was highest in the homozygous
mice. In both transgenic mice groups, from 21 dpi on severely
enlarged astrocytes with swollen nuclei were additionally found
adjacent to the inflammatory infiltrates. Some of these cells
displayed signs of apoptosis. Statistically, both transgenic animal
groups displayed significantly more GFAP-positive astrocytes than
non-transgenic BDV-infected mice (table S2) at 28 dpi (Tg/–:
p = 0.0471, Tg/Tg: p = 0.0177) and 35 dpi (Tg/–: p = 0.0400,
Tg/Tg: p = 0.0443).
The viral nucleoprotein (BDV-N) was detected 7 dpi in
single neurons in the cerebral cortex and hippocampus in all
BDV-infected mice groups, (Figs. 9J–L, 12). Between 21 and
49 dpi, BDV-N showed a disseminated distribution in the entire
brain in all infected mice cohorts reaching the maximum of
positive cells between 35 and 42 dpi. BDV-N was present in
neurons, astrocytes, oligodendrocytes and single ependymal cells.
In all cell types, the viral protein was found in the cytoplasm,
nucleus and processes as well in as in the neuropil from 21 dpi on.
Moreover, comparable quantity of BDV-N positive cells was
present in TNF-overexpressing brain areas compared to brain
regions with low or no transgenic TNF-expression in both
transgenic groups.
Infectious virus was isolated on 28 and 49 days p.i. in TNF-
transgenic and wild-type mice in similar titres ranging from 26103
up to 66103 REB-ID50 in each group.
The Spearman Rank Correlation, testing the direction
and strength of the relationship between two variables, displayed
significant correlations between the three different mice groups
(non-infected controls, mock-infected and BDV-infected animals)
and degree of encephalitis (p,0.0001, rs =0.96159). The severity
of encephalitis showed a correlation with the occurrence of
seizures (p = 0.005, rs = 0.78515).
Discussion
Due to the versatile effects of TNF, combination of TNF-
overexpression and experimental infection with a neurotropic
virus such as BDV is perfectly suitable to analyze the effect of
elevated TNF levels on the pathogenesis and outcome of
neurotropic virus infections. This might particularly affect clinical
signs, e.g. presensitation for epileptic seizures, host immune
response, reaction pattern of brain cells and viral spread in the
CNS. Intriguing actions of TNF in the CNS range from induction
of antiviral immune responses, proconvulsive and anticonvulsive
effects up to neurodegenerative and neuroprotective properties [1–
6,10,20,42,43,47,52–54]. Thus, a biological effect on BDV-
infection could be anticipated.
In the TNF-overexpressing mouse model, epileptic seizures after
BDV-infection were associated with a severe inflammatory
reaction and glial cell activation in the brain. Interestingly,
spontaneous seizures have only occasionally been noted in other
TNF-transgenic mice models [10,49]. The mice used in the
present study express murine TNF under the control of the
promoter of the receptor-subunit NR2B of the NMDA glutamate
receptor that guaranteed TNF-overexpression restricted to specific
forebrain areas where BDV is regularly present [25,34,52,55].
This was confirmed by quantification of TNFtg mRNA copy
numbers in cortex cerebri, striatum and hippocampus where these
levels were significantly higher than in the cerebellum. The absent
or very low copy numbers in the cerebellum reflect the age-
dependent NR2B expression [56]. NR2B mRNA levels were not
influenced by transgene expression or BDV-infection. Albeit
considerable more severe inflammatory brain lesions in the
homozygous infected mice, the separate analysis of each brain
area at 42 dpi did not reveal significant differences in the TNFtg
mRNA levels between heterozygous and homozygous mice.
However, in another own study using total brain sections at mid
hippocampal-thalamic levels at 21 and 42 dpi significantly higher
TNFtg mRNA levels in homozygous mice were measured when
Figure 12. Detection of viral antigen in the brain of BDV-infected animals. After 21 dpi, the viral nucleoprotein BDV-N showed a
disseminated and comparable distribution in the entire brain in all TNF-transgenic and wild-type animals. Score for the BDV-N immunoreactivity: 0:
no detection of antigen; 1: single foci with BDV-N positive cells in some brain areas,,80 cells per HPF; 2: less than 150 positive cells per HPF, neuropil
reaction, 3: more than 150 positive cells per HPF, distinct neuropil reaction p.i.: post infection, –/–: non-transgenic mice, Tg/–: heterozygous
transgenic mice, Tg/Tg: homozygous transgenic mice, median, bar: minimal/maximal value.
doi:10.1371/journal.pone.0041476.g012
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compared to the heterozygous cohort in a global comparison (data
not shown). This indicates that in the homozygous mice TNFtg
mRNA up-regulation is stronger early p.i. which can result in the
more pronounced appearance of inflammatory infiltrates, glial
activation and seizures in this cohort. Interestingly, TNFtg was
also able to induce native TNF mRNA, total TNF mRNA levels
consisted of approximately 50% native TNF mRNA. Therefore,
native TNF can further contribute to the transgenic TNF effects.
However, TNF mRNA levels did not increase significantly after
BDV-infection in the transgenic mice, approximately 2-fold higher
values were measured only in the hippocampus in the transgenic
mice. This indicates that the definite and significant TNF-effects
were most likely mediated by induction of additional factors as
shown by the significant increase of IL-1, TNFR1 and TNFR2
mRNA indicating a higher availability of both TNF receptors. In
experimental infection with Theiler virus, TNF, IL-6 and
associated inflammatory changes mainly contribute to the
occurrence of acute seizures [20,21].
There is increasing evidence that human epilepsy of various
etiologies is related to chronic inflammatory processes in the CNS
as cause and/or consequence of seizures [1,3,4,6,7,12]. Thus, the
encephalitis in the TNF-transgenic mice most likely represents one
important key factor for seizure induction. The occurrence of
seizures is furthermore influenced by the degree and extent of
inflammation and participating cell types [3,5] which can be
substantiated in the TNF-transgenic mice as the Spearman rank
correlation revealed a significant effect of the severity of
encephalitis on the occurrence of seizures. In the BDV-infected
TNF-transgenic mice, the amount of invading immune cells
correlated with the level of TNF-expression indicating that TNF
presensitizes a primarily less sensitive mouse brain for immune cell
invasion. The latter has been postulated as further trigger in the
epileptogenic process but seem to exert also neuroprotective
properties [1,57,58]. In general, the C57Bl/6 mouse line has been
described as less susceptible to BDV-induced disease but this strain
develops regularly an immune mediated disorder and clinical
disease in combination with a presensitizing event such as IL-12-
overexpression [24,36,59], comparable to the TNF-transgenic
mice. TNF effects are achieved by increasing the permeability of
the CNS blood brain barrier with induction of intercellular
adhesion molecule-1 and vascular cell adhesion molecule-1 [3,38].
These adhesion molecules can also be upregulated in endothelial
cells by seizures itself with subsequent activation of perivascular
glial cells [4,57]. In experimentally BDV-infected mice and rats,
an up-regulation of native TNF in the brain is regularly observed,
even very early after infection [31–33] which underlines the
essential role of TNF for the following inflammatory events also in
our mouse model. However, elevated TNF-levels might also act as
anticonvulsant because an astrocytic TNF-overexpression pre-
vented seizures in mice via the TNFR2 [10,42]. Most studies
confirmed this protective effect via TNFR2 whereas TNF
signaling via TNFR1 exert proconvulsive effects in most exper-
imental settings [2,6,42,43]. In the TNF-transgenic mice, up-
regulation of both TNFR mRNAs was detected after BDV-
infection so that anticonvulsant and proconvulsive TNF effects
might have been operative. In this respect it should be mentioned
that signaling via each TNFR does not represent an isolated
process but that TNFR cross talk influences the outcome of TNF
effects [47]. Further studies are warranted to elucidate these
multifunctional aspects of TNF expression.
Beside immune cell invasion CNS inflammation regularly
comprises activation of microglia followed by astrocytic responses
as present in the BDV-infected rats and TNF-transgenic mice
[25,34,55]. This can subsequently serve as further cytokine
source. The data confirmed the expected correlation of TNF-
expression, severe encephalitis and microglia activation but did
apparently not change the percentage of perivascular microglia/
macrophages in the total count of invading immune cells. It is
widely accepted that TNF is an important mediator for microglia
activation, e.g. reduced microglia activation was found in TNF-
knock out mice [60]. In BDV-infection microglia activation
seems to depend on persistent infection of neurons and activation
of astrocytes [61]. Microglial TNF and IL-1 production play an
important role in models mimicking CNS infections in children
as seizure predisposition [44,45]. The early and strong microglia
activation in the neonatally BDV-infected TNF-transgenic mice
was possibly comparably involved. In contrast, the astrogliosis
rather reflects an unspecific response to the virus infection since
also wild-type mice developed astrocyte activation. However,
astrogliosis was more severe in the transgenic animals during
increase of inflammation in the CNS and only TNF-transgenic
animal showed an unsual astrocytic hypertrophy. In contrast, in
BDV-infected, severely diseased MRL mice only a swelling of
astrocytes but no increase of GFAP-reactivity has been described
[24]. In C57Bl/6 mice, astrogliosis also occurred after infection
with the neurotropic rabies virus [62] so that the genetic
background might influence the astrocytic response. Astrocytes
have been attributed as important source of cytokines, mainly IL-
1ß, in epileptic brain tissue [2,3,6,10]. IL-1 mRNA was also
significantly upregulated after BDV-infection, predominantly in
TNF-overexpressing brain areas. Thus, the unusual astrocytic
hypertrophy in these regions might result from an altered
astrocytic reaction pattern with cytokine up-regulation, thereby
also triggering seizure induction.
The encephalitis in the TNF-transgenic mice has most likely
also increased the risk for seizures by altering excitability of
neurons or neuromodulatory responses as shown for other seizure
models [4,6,13,14,15,18,63]. There is increasing evidence that
cytokines such as TNF can interfere with the excitability of
neurons by mediating synaptic scaling, e.g. exocytosis of excitatory
AMPA receptors and endocytosis of inhibitory GABA A receptors
and via long term effects on gene expression involved in synaptic
reorganization, neurogenesis and cell death [2,6,13,63]. TNF is
furthermore involved in control of glutamatergic gliotransmission
by interaction with extrasynaptic NMDA receptors [43,64].
However, TNF-transgenic mice are protected against glutamate
excitoxicity mainly by up-regulation of TNFR2 signaling as shown
in vitro and in a retinal ischemia model and high TNF levels more
likely employ TNFR2 signaling [2,42,47,48,52,65]. Interestingly,
TNFR2 signaling pathway can be further stimulated by coactiva-
tion of NMDA receptors and this can serve as inherent protection
against glutamate-induced injuries [48]. Phenotypically, higher
extrasynaptic NMDA receptor currents have been measured in
acute hippocampal slice of young TNF-transgenic mice (data not
shown). Thus, high TNF mRNA values in transgenic regions
could have protected neurons even in case of BDV-infection since
no notable neuronal necrosis was detected in any of these areas
despite strong inflammatory lesions. No or only mild inflammation
was found in the hippocampus where levels of TNF mRNAs were
highest. It should be noted that cytokines may also affect the
threshold to seizures independent of cell death [10]. Since
neuronal morphology was well preserved, disturbances of the
excitability of neurons and/or neuromodulatory systems as shown
for the anticonvulsant dynorphin system have to be further
detailed and to put into context to potential glial dysfunctions
[8,9,14,18,66].
Beside seizures, TNF-transgenic animals also gained less weight
than the wild-type mice after BDV-infection. This was a general
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feature in all BDV-infected mice compared to mock-infected
animals. A reduced weight gain after BDV-infection has been
noted in neonatal or adult rats using the BDV strain that caused
the typical neurological type of BD [55,67]. For neonatally rats, it
was assumed that the lack of weight gain was due to the virus
infection itself but in experimental LCMV-infection of mice,
weight gain correlated with CD4+ T-cell activation rather than
with TNF expression [68]. Both opportunities could be involved in
our mouse model.
Strikingly, the viral spread within the brain and isolation of
infectious virus showed no obvious differences between the wild-
type and TNF-transgenic infected mice. The distribution of BDV-
N was similar as described for adult infected rats [25,34,55] and
indicates a persistent virus infection even in TNF-overexpressing
animals. A disseminated viral spread was also found in mice
deficient of several cytokines, chemokines or their receptors (IFNc,
Fas/FasL, CXCL10, CXCR3, inducible NO-synthase) [35,36].
Thus, BDV seems to adapt easily to different immunological
conditions to ensure its spread and persistence in the CNS.
Taken together, this study showed that high cerebral levels of
TNF in combination with a neurotropic virus infection caused
spontaneous epileptic seizures indicating a cause-and-effect-
relationship. In the present model, high levels of TNF presensitize
the mice brain to enhanced CNS inflammation with glial cell
activation accompanied by cytokine and TNFR up-regulation.
This demonstrates the impact of chronically elevated cytokine
levels and the complex neuro-immune interactions for seizure
induction which can be analyzed in appropriate animal models
such as the experimental BDV-infection of TNF-transgenic mice.
Materials and Methods
1. Mice and Experimental BDV-infection
C57Bl/6 homozygous (Tg/Tg, n= 25) and heterozygous (Tg/–,
n = 34) TNF-transgenic and non-transgenic (–/–, n= 30) mice
(total n = 89, [52]) were infected neonatally by intracerebral
injection of a mouse-adapted BDV-strain (10% BDV-infected
brain suspension 103 ID50/ml), kindly provided by P. Staeheli,
Department of Virology, University of Freiburg, Germany into the
frontal cerebral cortex. Mock-infected (n = 42, 14 mice per group)
and non-infected animals (n = 67, both transgenic groups n= 22,
non-transgenic mice n= 23) of the three experimental groups
served as controls. Male and female mice were used in equal
amounts. The studies were approved by the Regierungspra¨sidium
Hannover according to the guide for the care and use of animals in
the State of Lower Saxony (Application No. Az. 509.6-42502-03/
679). This also implies that all efforts have been made to minimize
suffering of any animal.
Infection rate was 100%. The mice were killed weekly between
7 and 49 days post infection (dpi) by using thiobarbiturate
followed by cervical dislocation. The brains were removed
immediately and cut sagitally, one half was fixed in formalin and
embedded in paraffin, the other half was embedded in OCTTM-
compound (Sakura, Finetec Europe, Zoeterwoude, The Nether-
lands), shock frozen and stored at 280uC.
2. Clinical Examination
Clinical and neurological examinations were carried out weekly
starting at 21 dpi. The investigations were performed according to
routine examination scheme for small animals [69] and based on
the results of the study done by Hallensleben et al. [24]. The body
weight was measured and different tests for the presence of
neurological deficits were performed: Activity, the gait on the grid
and on a flat surface as well as the ability to balance on a stick were
evaluated using semi quantitative scores by two independent
investigators and are detailed in table 1.
3. DNA Isolation and Quantitative PCR (qPCR)
For the analysis of the transgenic status of the mice, DNA was
isolated from mouse tails using the E.N.Z.A.H Tissue DNA Mini
Kit (Peqlab, Erlangen, Germany) according to the manufacturer’s
protocol. The transgenic status of the animals was determined
using the Comparative Quantitation Protocol of the Mx 4000
Multiplex Quantitative PCR System (StratageneH, La Jolla, CA)
and SYBR-GreenH (StratageneH) as fluorophore. DNA specimens
of a known homozygous animal served as calibrator, glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) levels were used as an
internal standard. One defined animal of each transgene status
(homozygous, heterozygous and non-transgenic) was used in each
run as control beside no template controls. All samples and
controls were applied as duplicates in each run. The analysis was
performed with primers detecting specifically the transgenic TNF
(251 bp, forward: CTG GAT ATT CCC AAC ATG CG, reverse:
CCC CGA ACG TCA GTA GAC AG; [50]) and primers specific
for the murine GAPDH (288 bp, GI: 6679936, forward: GAG
GCC GGT GCT GAG TAT GT, reverse: GGT GGC AGT
GAT GGC ATG GA) using 40 cycles with 55uC as annealing
temperature. A relative quantity (dRN =22DDCt) of 0 character-
Table 1. Scoring of the clinical-neurological examination.
Score activity
gait on grid/
flat surface ability to balance on a sticksensitivity grasp/withdrawal reflex




3 severe hyperactivity severe unsteady gait severe unsteadiness / /
2 moderate hyperactivity moderate unsteady gait moderate unsteadiness severe hyperesthesia severe hyperreflexia
1 mild hyperactivity mild unsteady gait mild unsteadiness mild hyperesthesia mild hyperreflexia
0 normal normal no problems normal normal
21 mild hypoactivity / / mild hypoesthesia mild hyporeflexia
22 moderate hypoactivity / / severe hypoesthesia severe hyporeflexia
23 apathy / / / /
doi:10.1371/journal.pone.0041476.t001
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ized non-transgenic mice. Heterozygous animals had a dRN of
0.3–0.7, whereas homozygous animals showed a dRN $0.8.
4. RNA Isolation and Quantitative RT-PCR
Highly transgenic TNF expressing brain areas such as cortex
cerebri, hippocampal formation and striatum were excised from a
sagittally cut brain section (42 dpi, n = 3 per group, approximately
bregma 22.18 mm, interaural 1.62 mm [70]) of BDV-infected
and non-infected mice. The cerebellum served as control brain
region. New sterile scalpels were used for every brain region and
mouse to avoid any contamination. RNA was isolated from these
brain regions using TrizolH Reagent (Invitrogen, Karlsruhe,
Germany) and purified using the RNeasy Minikit (Qiagen,
Hilden, Germany) following the protocols of the supplier. After
a digestion step with DNase I (Qiagen, Hilden, Germany), RNA
was resuspended in 30 ml of RNAse-free water. Reverse
transcription was performed applying the OmniskriptH RT Kit
(Qiagen, Hilden, Germany) and random primers (Promega,
Madison) as described elsewhere [71]. The reaction took place
in a final volume of 19 ml in buffer containing 0.2 mM dNTP mix,
0.5 ml Random Primer primer (Promega, Madison), 10 units
RNaseOutTM Recombinant Ribonuclease Inhibitor (InvitrogenTM
GmbH, Karlsruhe, Germany), 4 units of OmniskriptH enzyme
and 12 ml of total RNA.
Real-time quantitative RT-PCR analysis for the mRNA of
transgenic TNF (TNFtg) applying the primer pairs used for the
analysis of the transgene status (see before), total TNF (TNFto,
203 bp, NM013693, forward: GCC TCT TCT CAT TCC TGC
TT, reverse: CAC TTG GTG GTT TGC TAC GA), IL-1a
(179 bp, NM010554, forward: AAG CAA CGG GAA GAT
TCT GA, reverse: TGA CAA ACT TCT GCC TGA CG),
TNFR1 (197 bp, NM011609, forward: CAG TCT GCA GGG
AGT GTG AA, reverse: CAC GCA CTG GAA GTG TGT CT),
TNFR2 (171 bp, NM011610, forward: TAC CAA GGG TGG
CAT CTC TC, reverse: TCC TGG GAT TTC TCA TCA GG),
NR2B (199 bp, NM008171 forward: TCC GAA GCT GGT
GAT AAT CC, reverse: GAG AGG GTC CAC ACT TTC CA)
and for the housekeeping genes glyceraldehyde-3-phosphate
dehydrogenase (GAPDH, 288 bp, BC085275, forward: GAG
GCC GGT GCT GAG TAT GT, reverse: GGT GGC AGT
GAT GGC ATG GA), hypoxanthine phosphoribosyl-transferase-
1 (HPRT, 169 bp, BC083145, forward: GGA CCT CTC GAA
GTG TTG GA, reverse: TTG CGC TCA TCT TAG GCT TT)
and b-actin (233 bp, NM007393, forward: GGC TAC AGC
TTC ACC ACC AC, reverse: ATG CCA CAG GAT TCC ATA
CC) gene were performed using the Mx3005H Multiplex
Quantitative PCR System (StratageneH) and SYBR-GreenH
(StratageneH) as fluorophore as previously described [53]. The
thermal profile was set as follows: 10 minutes at 95uC followed by
40 cycles with an annealing temperature of 60uC (TNFtg, TNFto,
IL-1, TNFR1, TNFR2, NR2B, b-actin), 57uC (GAPDH) or 55uC
(HPRT) for 60 seconds and 30 seconds at 72uC. Amplification of
the cDNA was carried out using the BrilliantH QPCR Core
Reagent Kit (StratageneH). Estimation of the cDNA copy numbers
for each gene was performed using a 10-fold serial dilution of
appropriate cloned cDNA samples ranging from 107 2101 copies
to generate standard curves as recently described [71]. The
reference genes (GAPDH, HPRT and b-actin) were used for
normalization of TNFtg, TNFto, TNFR1, TNFR2, IL-1 and
NR2B mRNA copy numbers using geNorm (http://medgen.
ugent.be/˜ jvdesomp/genorm/) according to Vandesompele et al.
[72].
5. Histology
Formalin-fixed and paraffin-embedded brain sections were
stained with hematoxylin and eosin (H&E) to assess the degree
of encephalitis as defined by the presence of histopathological
changes and mononuclear immune cell infiltrates at all time points
investigated. The distribution of the lesions was investigated
employing at least nine different brain regions including regions
with high TNF-overexpression (cortex cerebri, striatum, hippo-
campus, thalamus), and low TNF-overexpression (hypothalamus,
amygdala, mesencephalon) and non-expressing areas (cerebellum,
medulla oblongata). The inflammatory reaction of leptomeningeal,
perivascular and parenchymal infiltrates was scored within a 400-
fold magnification as follows: 0: no inflammatory lesions; 1 (mild
inflammation): up to 4 perivascular or leptomeningeal immune
cells, perivascular cuffs with up to one layer of invading immune
cells and up to 5 activated microglia surrounding the respective
infiltrate; 2 (moderate inflammation): seven and more perivascular
or leptomeningeal immune cells, perivascular cuffs of mostly 1–2
layers of invading immune cells and up to 20 activated microglia
surrounding the particular infiltrate; 3 (severe inflammation):
many perivascular or leptomeningeal immune cells, additional
parenchymal immune cell foci, perivascular cuffs with three and
more layers of invading immune cells and more than 20 activated
microglia surrounding the respective infiltrate. The number of
reactive microglia cells adjacent to the perivascular immune cell
infiltrates in H&E-stained sections (cells with rod-shaped nuclei,
perineuronal location) was counted in one high power field (HPF,
400-fold magnification) focusing the respective vessel in the center
of the HPF. The average number per animal was calculated. The
microglia origin of the rod shaped cells was confirmed by
immunostaining with an antibody against mac-1a (eBioscience,
San Diego, CA, 1:3000 in PBS with 1% bovine serum albumine
[BSA]; see below).
6. Immunohistochemistry (IHC)
Macrophages and microglia were recognized using a primary
rat monoclonal antibody (mac-1a; eBioscience, San Diego, 1:3000
in PBS with 1% BSA). The IHC was performed using serial frozen
tissue sections and the ABC method (ABC Elite Standard [PK-
6100], Vector Laboratories, Burlingame, CA) with 3,39-diamono-
benzidine (DAB) as substrate, adapting the protocols for paraffin
embedded slides [34] and making the required adjustments. The
sections were fixed for 10 minutes in acetone and processed
without the unnecessary steps of deparaffination and antigen
unmasking. The primary antibody was incubated for 1 h at room
temperature. For quantitative evaluation of the percentage of
perivascular inflammatory cells, immunostained cells were deter-
mined 42 dpi. The total numbers of cells in the cuffs were used as
denominator and for each mouse brain. About 200 cells were
counted followed by calculation of the particular percentage of
mac-1a positive cells. The inflammatory infiltrates were counted in
at least six different brain regions (cortex cerebri, striatum,
hippocampus, thalamus, hypothalamus, amygdala) in all BDV-
infected groups.
IHC using antibodies specific for glial fibrillary acidic protein
(GFAP) and the BDV-nucleoprotein (BDV-N) was performed at
all time points investigated using paraffin-embedded tissue sections
and the ABC method (ABC Elite Standard [PK-6100], Vector
Laboratories) with 3,39-diamonobenzidine (DAB) as substrate as
previously described [55]. GFAP was detected using a polyclonal
rabbit antibody (DakoCytomation, Hamburg, Germany, 1:1000 in
PBS with 20% normal swine serum) and BDV-infection was
confirmed using a monoclonal anti-BDV-N antibody (Bo18; 1:500
in PBS with 1% BSA). The distribution and density of cells
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expressing GFAP and BDV-N was investigated employing at least
nine different brain regions (cortex cerebri, striatum, hippocam-
pus, thalamus, hypothalamus, amygdala, mesencephalon, cerebel-
lum, medulla oblongata) in Tg/Tg, Tg/– and –/– animals of the
non-infected, BDV-infected and mock-inoculated mice groups.
Semiquantitiative analysis of GFAP expression was performed
using 100-fold and 400-fold magnification and was scored as
follows: 0: no GFAP expressing cells; 1 (mild astrogliosis): less than
30 positive cells per HPF, positive cells mainly in cortex cerebri,
hippocampus and striatum; 2 (moderate astrogliosis): 30–60
positive cells per HPF, some astrocytes exhibit swollen nuclei; 3
(severe astrogliosis): more than 60 positive cells per HPF.
Semiquantitiative analysis of the BDV-N immunoreactivity was
performed using 100-fold and 400-fold magnification and was
evaluated as follows: 0: no detection of antigen; 1: single foci with
BDV-N positive cells in some brain areas, less than 80 cells per
HPF, no reaction within the neuropil; 2: less than 150 positive cells
per HPF, neuropil reaction, BDV-N positive cells in nearly all
brain regions; 3: more than 150 positive cells per HPF, distinct
neuropil reaction, BDV-N positive cells in all brain regions
investigated.
7. Detection of Infectious Virus
The isolation of infectious virus from fresh frozen TissueTek-
embedded brain tissue of BDV-infected TNF-transgenic and wild-
type mice (28 and 49 days p.i.) and determination of the virus titre
were performed employing susceptible fetal rabbit brain cells;
visualization was done by indirect immunofluorescence techniques
(IIFT) according to previous protocols [73]. The virus titre was
determined as REB-ID50 (infectious dose 50 for embryonic rabbit
brain cells).
8. Statistics
The statistical evaluation of weight gain was performed using
the analysis of variance for repeated measurements concerning the
mean weight gain of each mouse group and infection (table S1).
Additionally, a three-way analyses including three two-way and
three one-way analysis of variance were carried out for the
evaluation of TNFtg, TNFto, IL-1, TNFR1, TNFR2 and NR2B
mRNA levels correlating brain region, transgene expression and
infection (tables S3, S4). To achieve normal distribution, these
data were logarithmically transformed. Furthermore, for compar-
ison of gene copy numbers within the mouse groups, Tukey’s post-
hoc test for multiple pairwise comparisons was applied. The other
parameters of the clinical examinations, the results of the
histological scoring, the activation of microglia and astrocytes as
well as the results of the immunohistological staining for BDV-N
and GFAP of the different mice groups as well as comparison of
the different time points of infection within one group were
analyzed by using Wilcoxon Scores and Kruskal-Wallis Tests
(table S2). The Spearman rank correlation coefficient was used to
calculate for relationship of the status of infection, occurrence of
seizures and degree of inflammation. For all statistical analysis,
differences were considered significant if P-values were ,0.05. All
statistical calculations were performed using the statistical software
SASH 9.1 (SAS Institute Inc., Cary, NC).
Supporting Information
Figure S1 GFAP-immunostaining of hippocampi of
BDV-infected animals. Astrogliosis occured in all BDV-
infected mice groups but was more servere in transgenic animals.
There were no differences between hippocampal areas such as
CA1 and dentate gyrus. 42 dpi, bar: 50 mm, –/–: non-transgenic
mice, Tg/–: heterozygous transgenic mice, Tg/Tg: homozygous
transgenic mice.
(PDF)
Table S1 Statistics of weight gain. The statistical evaluation
of weight gain was performed using the analysis of variance for
repeated measurements concerning the mean weight gain of each
mouse group and infection. The respective p-values are given. –/–:
non-transgenic mice, Tg/–: heterozygous transgenic mice, Tg/Tg:
homozygous transgenic mice.
(PDF)
Tables S2 Statistics of clinical investigation, encephali-
tis and glia activation. The clinical examinations, the
histological scoring and the activation of microglia and astrocytes
of the different mice groups as well as comparison of the different
time points of infection within one group were analyzed by using
Wilcoxon Scores and Kruskal-Wallis Tests. The respective p-
values are given. –/–: non-transgenic mice, Tg/–: heterozygous
transgenic mice, Tg/Tg: homozygous transgenic mice.
(PDF)
Table S3 Statistics of qRT-PCR assays. A three-way
analyses including three two-way and three one-way analysis of
variance were carried out for the evaluation of TNFtg, TNFto, IL-
1, TNFR1, TNFR2 and NR2B mRNA levels correlating brain
region, transgene expression and infection. To achieve normal
distribution, these data were logarithmically transformed. For
comparison of gene copy numbers within the mouse groups,
Tukey’s post-hoc test for multiple pairwise comparisons was
applied. The respective p-values are given. –/–: non-transgenic
mice, Tg/–: heterozygous transgenic mice, Tg/Tg: homozygous
transgenic mice.
(PDF)
Table S4 Additional statistical information of qRT-PCR
assays. A three-way analyses including three two-way and three
one-way analysis of variance were carried out for the evaluation of
TNFtg, TNFto, IL-1, TNFR1, TNFR2 and NR2B mRNA levels
correlating brain region, transgene expression and infection. As
additional information p-values were completed by F-values and
degree of freedom. –/–: non-transgenic mice, Tg/–: heterozygous
transgenic mice, Tg/Tg: homozygous transgenic mice.
(PDF)
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